126 related articles for article (PubMed ID: 30068256)
21. Flexible extension of the accelerated failure time model to account for nonlinear and time-dependent effects of covariates on the hazard.
Pang M; Platt RW; Schuster T; Abrahamowicz M
Stat Methods Med Res; 2021 Nov; 30(11):2526-2542. PubMed ID: 34547928
[TBL] [Abstract][Full Text] [Related]
22. Correcting for heterogeneity and non-comparability bias in multicenter clinical trials with a rescaled random-effect excess hazard model.
Goungounga JA; Grafféo N; Charvat H; Giorgi R
Biom J; 2023 Apr; 65(4):e2100210. PubMed ID: 36890623
[TBL] [Abstract][Full Text] [Related]
23. A flexible approach to time-varying coefficients in the Cox regression setting.
Sargent DJ
Lifetime Data Anal; 1997; 3(1):13-25. PubMed ID: 9384623
[TBL] [Abstract][Full Text] [Related]
24. Simulating survival data with predefined censoring rates for proportional hazards models.
Wan F
Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
[TBL] [Abstract][Full Text] [Related]
25. A parametric additive hazard model for time-to-event analysis.
Voeltz D; Hoyer A; Forkel A; Schwandt A; Kuß O
BMC Med Res Methodol; 2024 Feb; 24(1):48. PubMed ID: 38402386
[TBL] [Abstract][Full Text] [Related]
26. A flexible parametric accelerated failure time model and the extension to time-dependent acceleration factors.
Crowther MJ; Royston P; Clements M
Biostatistics; 2023 Jul; 24(3):811-831. PubMed ID: 35639824
[TBL] [Abstract][Full Text] [Related]
27. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
Royston P; Parmar MK
Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
[TBL] [Abstract][Full Text] [Related]
28. A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non-linear and non-proportional effects of covariates.
Charvat H; Remontet L; Bossard N; Roche L; Dejardin O; Rachet B; Launoy G; Belot A;
Stat Med; 2016 Aug; 35(18):3066-84. PubMed ID: 26924122
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the generalized gamma and exponentiated Weibull distributions.
Cox C; Matheson M
Stat Med; 2014 Sep; 33(21):3772-80. PubMed ID: 24700647
[TBL] [Abstract][Full Text] [Related]
30. Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.
Joeng HK; Chen MH; Kang S
Lifetime Data Anal; 2016 Jan; 22(1):38-62. PubMed ID: 25772374
[TBL] [Abstract][Full Text] [Related]
31. The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?
Rauch G; Brannath W; Brückner M; Kieser M
Methods Inf Med; 2018 May; 57(3):89-100. PubMed ID: 29719915
[TBL] [Abstract][Full Text] [Related]
32. Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer.
Wang SJ; Kalpathy-Cramer J; Kim JS; Fuller CD; Thomas CR
AMIA Annu Symp Proc; 2010 Nov; 2010():847-51. PubMed ID: 21347098
[TBL] [Abstract][Full Text] [Related]
33. Dynamic regression hazards models for relative survival.
Cortese G; Scheike TH
Stat Med; 2008 Aug; 27(18):3563-84. PubMed ID: 18338318
[TBL] [Abstract][Full Text] [Related]
34. On hazard-based penalized likelihood estimation of accelerated failure time model with partly interval censoring.
Li J; Ma J
Stat Methods Med Res; 2020 Dec; 29(12):3804-3817. PubMed ID: 32689908
[TBL] [Abstract][Full Text] [Related]
35. A permutation test based on the restricted mean survival time for comparison of net survival distributions in non-proportional excess hazard settings.
Wolski A; Grafféo N; Giorgi R;
Stat Methods Med Res; 2020 Jun; 29(6):1612-1623. PubMed ID: 31456485
[TBL] [Abstract][Full Text] [Related]
36. Heritability, reliability of genetic evaluations and response to selection in proportional hazard models.
Yazdi MH; Visscher PM; Ducrocq V; Thompson R
J Dairy Sci; 2002 Jun; 85(6):1563-77. PubMed ID: 12146489
[TBL] [Abstract][Full Text] [Related]
37. Impact of a non-constant baseline hazard on detection of time-dependent treatment effects: a simulation study.
Jachno K; Heritier S; Wolfe R
BMC Med Res Methodol; 2021 Aug; 21(1):177. PubMed ID: 34454428
[TBL] [Abstract][Full Text] [Related]
38. An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect.
Royston P; Parmar MK
Trials; 2014 Aug; 15():314. PubMed ID: 25098243
[TBL] [Abstract][Full Text] [Related]
39. Robustness of the quartiles of survival time and survival probability.
Hemyari P
J Biopharm Stat; 2000 Aug; 10(3):299-318. PubMed ID: 10959913
[TBL] [Abstract][Full Text] [Related]
40. Comparing proportional hazards and accelerated failure time models for survival analysis.
Orbe J; Ferreira E; Núñez-Antón V
Stat Med; 2002 Nov; 21(22):3493-510. PubMed ID: 12407686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
